Live Breaking News & Updates on Interdisciplinary Genitourinary Oncology

Stay updated with breaking news from Interdisciplinary genitourinary oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Grünwald on Examining Progression Patterns for Lenvatinib Plus Pembrolizumab in Advanced RCC

Dr Grünwald on Examining Progression Patterns for Lenvatinib Plus Pembrolizumab in Advanced RCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

University Hospital Essen , Interdisciplinary Genitourinary Oncology ,

Lenvatinib/Pembrolizumab Maintained Beneficial Outcomes When Evaluated by Tumor Size in RCC

Lenvatinib/pembrolizumab demonstrated efficacy irrespective of tumor burden in advanced renal cell carcinoma in the overall patient population of the phase 3 CLEAR study. ....

United States , Lenvatinib Lenvima , University Hospital Essen , Interdisciplinary Genitourinary Oncology , Subgroup Analysis , Western Europe , North America , Immunotherapy In Gu Cancers , Genitourinary Cancers , Immuno Oncology ,

Expert: Combination of Lenvatinib, Pembrolizumab Outperformed Sunitinib in the Treatment of Advanced RCC

Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma. ....

Viktor Grunwald , Axel Kock , European Society Of Medical Oncology , University Hospital Essen , Pharmacy Times , Interdisciplinary Genitourinary Oncology , Medical Oncology ,